Overexpression of ABCC1 Confers Drug Resistance to Betulin
- Front Oncol. 2021 Feb 25;11:640656. doi: 10.3389/fonc.2021.640656.
- 1. College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, China.
- 2. Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY, United States.
Betulin is a lupane-type pentacyclic triterpene, which is isolated from birch bark. It has a broad spectrum of biological and pharmacological properties, such as anti-inflammatory, anti-tumor, anti-viral, and anti-bacterial activity. Herein, we explored the factors that may result in betulin resistance, especially with respect to its interaction with ATP-binding cassette subfamily C member 1 (ABCC1). ABCC1 is an important member of the ATP-binding cassette (ABC) transporter family, which is central to mediating multidrug resistance (MDR) in naturally derived Anticancer agents. An MTT-based cell viability assay showed that ABCC1 overexpression has the ability to desensitize both Cancer cell line and gene-transfected cell line to betulin and that this betulin-induced resistance can be antagonized by a known ABCC1 inhibitor MK571 at 25 μM. Additionally, betulin upregulates the ABCC1 protein expression level in both concentration-dependent and time-dependent manners, also blocks the transport function mediated by ABCC1. Subsequently, a high affinity score of betulin was achieved in a computational docking analysis, demonstrating a strong interaction of betulin with ABCC1.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer